Biodexa Pharmaceuticals Plc
BDRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20 | $0 | $1 | $5 |
| - Cash | $2 | $6 | $3 | $10 |
| + Debt | $1 | $0 | $1 | $1 |
| Enterprise Value | $19 | -$5 | -$1 | -$5 |
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | -100% | -45.5% | 20.9% | – |
| Gross Profit | -$5 | -$4 | -$4 | -$4 |
| % Margin | – | -967.5% | -631.2% | -705.2% |
| EBITDA | -$9 | -$7 | -$8 | -$6 |
| % Margin | – | -1,879.5% | -1,181.8% | -979.1% |
| Net Income | -$6 | -$7 | -$8 | -$5 |
| % Margin | – | -1,858% | -1,095.3% | -944.6% |
| EPS Diluted | -115,700 | -22,900 | -494,300 | -352,500 |
| % Growth | -405.2% | 95.4% | -40.2% | – |
| Operating Cash Flow | -$12 | -$7 | -$7 | -$6 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$13 | -$7 | -$7 | -$6 |